Global Bisphosphonate Drug Market Professional Survey Report 2019
Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
The global Bisphosphonate Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bisphosphonate Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bisphosphonate Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bisphosphonate Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bisphosphonate Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Alendronate
Risedronate
Zoledronic acid
Other Bisphosphonate Drug
Segment by Application
Postmenopausal osteoporosis
Men with osteoporosis
Paget’s disease
Bone loss caused by cancer treatment
Osteoporosis imperfecta in children
The global Bisphosphonate Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bisphosphonate Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bisphosphonate Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bisphosphonate Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bisphosphonate Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Alendronate
Risedronate
Zoledronic acid
Other Bisphosphonate Drug
Segment by Application
Postmenopausal osteoporosis
Men with osteoporosis
Paget’s disease
Bone loss caused by cancer treatment
Osteoporosis imperfecta in children
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
